Relevium Technologies – Relevium is a publicly traded corporation strategically focused on the expansion and acquisition of entrepreneurial brands within the health and wellness sector. Our focus is on being a trusted source of high-quality nutraceutical and CBD products.
Relevium creates shareholder value by aggregating entrepreneurial health and wellness e-brands through a shared success structure that allows investors to secure excellent value at source and while seeking enhanced valuations in the public capital markets.
Biocannabix Health Corporation Inc. (“BCX”) is a wholly-owned subsidiary of Relevium Technologies with a focus on Nutraceutical and Pharmaceutical of cannabinoid infused formulations for pediatric and adult medical applications. The company’s head offices are located in Montreal, Quebec and is the process of designing and building a fully integrated organic cultivation and processing GMP facility in based in Montreal, Quebec. The brand portfolio includes Biocannabix® and Cannakids®.
BCX is building out a fully integrated organic cultivation facility based in Montreal, Quebec. The facility will house R&D and support in-house brands.
BioGanix is a cutting-edge line of weight-loss, health, beauty improvement and fitness supplements and products. BioGanix products help people lose weight, become healthier, happier, and most importantly achieve the results that our customers are looking for.
BioGanix has some of the best-selling products in the Health and Personal Care category on Amazon, and a loyal customer base. The combination of online marketing with an emphasis on superior quality products backed by stringent scientific research and formulations, this has developed BioGanix in becoming one of the leading dietary supplement brands in the U.S.
Since acquiring the BioGanix brand in 2017, Relevium grew its product line to 45 products and expanded its distribution channels as the company is now selling on Walmart.com in the United States. Relevium has also increased the BioGanix brand internationally as it is now available on Amazon.co.uk. Relevium will continue to execute on its global growth strategy with the European market insight and soon the Canadian market. Relevium will continue to innovate with the BioGanix brand, expand the product line and distribution channels to further drive growth.
BioGanix continues to increase its brand and customer base in the Health and Wellness sector through increased product offerings, distribution channels and international footprint.
What We Do
Relevium is a publicly traded corporation strategically focused the acquisition of e-retail brands, products and technologies in the health and wellness market. Relevium’s products are part of the $3.72 trillion dollar global wellness industry — one of the fastest growing worldwide markets. Our specific focus is on products that promote overall health, nutraceuticals, fitness nutrition and cosmeceuticals. The company already has 25 products being sold on Amazon with more being planned.
Who We Are
Relevium’s solid management team combines strong scientific knowledge and marketing know-how. The company leverages this experience to get the best out of the targets they acquire, while developing their own product lines.
Relevium also builds partnerships with other firms to expand their product lines. Relevium has recently announced an agreement with Salvenia Nutrition of Montreal and Biodevas Laboratories to develop an exclusive brand and product line of nutraceuticals and phytoceuticals targeted to pet care owners on a direct-to-consumer basis. Relevium has also retained Salvenia, a leading pet and livestock nutrition company, to lead the market research and the product line formulation process.